Regenix Drugs Limited - Company Profile

It is a healthcare public limited company based in Chennai, Tamil Nadu, India, established in 2007.
2007 Chennai, Tamil Nadu, India Active
Last Updated:
Access Report
About Regenix Drugs Limited

Regenix Drugs Limited, a active public limited company, was established on 10 May 2007 in Chennai, Tamil Nadu, India. Engaging in medical equipment retail & distribution within the manufacturing sector, it holds CIN: U24232TN2007PLC063446. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹21.55 Cr and a paid-up capital of ₹18.08 Cr.

Formerly known as Regenix Drugs Private Limited. It upholds a compliant status. Employing 830 professional, Its leadership includes Malathi Ramamurthy (Director), Ayyamperumal (Director), Krishanamoorthy Nirosha (Whole-Time Director). Past directors included Jerome Zacharias, Saleem Mohamed Mohamed Haniffa, Ravindran Kumeran. It holds ₹11.86 Cr open charges and ₹17.81 Cr settled loans. Its latest AGM occurred on 22 September 2024, with the balance sheet filed on 31 March 2024. It is based at Jamal Sonu Terrace, 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24232TN2007PLC063446

  • Registration Number

    063446

  • Incorporation Date

    10 May 2007

  • Authorized Capital

    ₹21.55 Cr

  • Paid-Up Capital

    ₹18.08 Cr

  • ROC Code

    Roc Chennai

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 21.55 Cr
  • Paid Up Capital ₹ 18.08 Cr
  • Company Age 18 Year, 9 Months
  • Last Filing with ROC 31 Mar 2024
  • Open Charges ₹ 11.86 Cr
  • Satisfied Charges ₹ 17.81 Cr
  • Revenue Growth **** 9.70%
  • Profit Growth **** 0.30%
  • Ebitda **** -3.29%
  • Net Worth 17.22%
  • Total Assets **** 14.89%
Company report

Regenix Drugs Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Regenix Drugs Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Regenix Drugs Limited?
Current Directors
Name Designation Appointment Date Status
Malathi Ramamurthy Director 15 Apr 2012 Current
Ayyamperumal Director 26 Aug 2019 Current
Krishanamoorthy Nirosha Whole-Time Director 21 Jun 2021 Current
Guhan Ramamurthy Director 21 Jun 2021 Current
Balaji Ramamurthy Whole-Time Director 01 Oct 2022 Current
Govindarajan Venkatakrishna Director 20 Mar 2010 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 14 Jun 2008 Past
Pramod Abcsdd Director 22 Aug 2022 Past
Pramod Abcsdd Director 15 Apr 2012 Past
Pramod Abcsdd Director 15 Apr 2012 Past
Pramod Abcsdd Additional Director 01 Oct 2016 Past
Pramod Abcsdd Director 01 Apr 2016 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Regenix Drugs.

Regenix Drugs Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 9.7% increase. The company also saw a slight improvement in profitability, with a 0.3% increase in profit. The company's net worth Soared by an impressive increase of 17.22%.

Regenix Drugs revenue growth over time
Regenix Drugs profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 9.70%
*******
*******
*******
*******
Revenue from Operations
*******
 9.38%
*******
*******
*******
*******
Total Assets
*******
 14.89%
*******
*******
*******
*******
Profit or Loss
*******
 0.30%
*******
*******
*******
*******
Net Worth
*******
 17.22%
*******
*******
*******
*******
EBITDA
*******
 -3.29%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Regenix Drugs?

In 2024, Regenix Drugs had a promoter holding of 62.97% and a public holding of 37.03%. The company had 2 Subsidiaries. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹118,609,222.00

Satisfied Charges

₹178,148,245.38

Charges Breakdown by Lending Institutions
  • Hdfc Bank Limited : 11.71 Cr
  • Axis Bank Limited : 0.15 Cr
Latest Charge Details
Date Lender Amount Status
10 Jan 2024 Hdfc Bank Limited ₹5.12 M Open
05 Sep 2023 Hdfc Bank Limited ₹2.12 M Open
13 Jul 2020 Hdfc Bank Limited ₹10.99 Cr Open
29 Jul 2015 Axis Bank Limited ₹1.47 M Open
17 Jul 2017 Others ₹7.99 Cr Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Regenix Drugs?

Regenix Drugs has a workforce of 830 employees as of Mar 20, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Regenix Drugs, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Regenix Drugs's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Regenix Drugs
Recent Activity within the Organization
  • Charges

    A charge with Hdfc Bank Limited of Rs. 10.99 Cr registered on 13 Jul 2020 with Charge ID 100362965 was modified on 21 Jan 2025. was recorded as a recent event.

  • Annual General Meeting

    The activity Regenix Drugs Limited last Annual general meeting of members was held on 22 Sep 2024 as per latest MCA records. was completed.

  • Balance Sheet

    Progress on Regenix Drugs Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.

  • Charges

    Progress on A charge with Hdfc Bank Limited amounted to Rs. 0.51 Cr with Charge ID 100907370 was registered on 10 Jan 2024. was documented.

  • Director Appointment

    Progress on Radhakrishnan Venu Murali was appointed as a Director was appointed as a Director on 24 Sep 2023 & has been associated with this company since 2 years 5 months . was documented.

  • Charges

    The activity A charge with Hdfc Bank Limited amounted to Rs. 0.21 Cr with Charge ID 100786726 was registered on 05 Sep 2023. was completed.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Regenix Drugs Limited?

The CIN of Regenix Drugs Limited is U24232TN2007PLC063446.

Where is Regenix Drugs Limited headquartered?

Regenix Drugs Limited is headquartered at Jamal Sonu Terrace, 42/1 Loganathan Nagar First Street, 100 Feet Road, Choolaimedu, Chennai, Tamil Nadu, 600094.

When was Regenix Drugs Limited incorporated?

Regenix Drugs Limited was incorporated on 10 May 2007.

Who are the current directors of Regenix Drugs Limited?

The current directors of Regenix Drugs Limited are

What is the primary industry of Regenix Drugs Limited?

The primary industry of Regenix Drugs Limited is Manufacturing.

Is Regenix Drugs Limited a listed company?

Regenix Drugs Limited is unlisted.

What is the capital structure of Regenix Drugs Limited?

The authorized capital of Regenix Drugs Limited is ₹21.55 Cr, and the paid-up capital is ₹18.08 Cr.

What is the compliance status of Regenix Drugs Limited?

The compliance status of Regenix Drugs Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available